The over-expression of BRD7 in NPC cells results in the downregulation of the c-jun, p-MEK and p-ERK1/2 expression and Ap-1 promoter inactivity, therefore, BRD7 plays a negative role in the MEK/ERK/MAPK pathway [29]. The gene discussed is FOS; the disease is nasopharyngeal carcinoma.